Webhaber
Experts temper hope for new FDA-approved Alzheimer’s drug

Experts temper hope for new FDA-approved Alzheimer’s drug

Lecanemab, marketed under the brand name Leqembi, is the second Alzheimer’s drug to receive U.S. regulatory approval in two decades, but Canadian experts say its potential benefits come with significant caveats

The Globe And Mail The Globe And Mail | Go to detail of news source

The Globe And Mail , Benzer haberler

The Globe And Mail Evening Update: Rogers-Shaw deal clears another hurdle; Polley among Oscar nominees Evening Update: Rogers-Shaw deal clears another hurdle; Polley among Oscar nominees
The Globe And Mail Toronto police issue arrest warrant in death of retired CBC editor Michael Finlay Toronto police issue arrest warrant in death of retired CBC editor Michael Finlay
The Globe And Mail Ottawa asking RCMP to ban use of sponge rounds, CS gas for crowd control Ottawa asking RCMP to ban use of sponge rounds, CS gas for crowd control
The Globe And Mail Ontario to lower age for mammograms to 40 from 50 next year Ontario to lower age for mammograms to 40 from 50 next year
The Globe And Mail Japanese parent company to shut down Quebec COVID-19 vaccine manufacturer Medicago Japanese parent company to shut down Quebec COVID-19 vaccine manufacturer Medicago
The Globe And Mail B.C. commits to mandatory Holocaust education for Grade 10 students B.C. commits to mandatory Holocaust education for Grade 10 students